Projects per year
UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. Our work contributes towards the following SDG(s):
-
SDG 1 No Poverty -
SDG 2 Zero Hunger -
SDG 3 Good Health and Well-being -
SDG 4 Quality Education -
SDG 5 Gender Equality -
SDG 6 Clean Water and Sanitation -
SDG 8 Decent Work and Economic Growth -
SDG 9 Industry, Innovation, and Infrastructure -
SDG 10 Reduced Inequalities -
SDG 11 Sustainable Cities and Communities -
SDG 15 Life on Land -
SDG 16 Peace, Justice and Strong Institutions -
SDG 17 Partnerships for the Goals
Fingerprint
Dive into the research topics where Pharmacy Practice and Pharmaceutical Sciences is active. These topic labels come from the works of this organization's members. Together they form a unique fingerprint.
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Profiles
-
Grant W Anderson
- Pharmacy Practice and Pharmaceutical Sciences - Associate Professor, Head
Person: Faculty, Executive, Administrative, and Managerial Staff
-
-
-
Overcoming Treatment Resistance in Pancreatic Cancer by Targeting Mitochondrial Glutamine and Pyruvate
Ronayne, C. T. (PI) & Stenehjem, D. D. (Co-Principal Investigator)
Whiteside Inst. for Clinical Research
1/1/26 → 12/31/26
Project: Research project
-
Real World Treatment Patterns in mPC by Hormone Sensitivity and HRRm Status
Stenehjem, D. D. (PI)
THE UNIVERSITY OF UTAH, PFIZER, INC.
12/16/25 → 12/31/26
Project: Research project
-
Aging-associated mitochondrial circular RNAs
Mun, H., Ham, D. W., Kim, N. C., Kwon, B. I., Kim, Y. K. & Yoon, J. H., 2026, In: Aging. 18, 1, p. 30-44 15 p.Research output: Contribution to journal › Article › peer-review
Open Access -
A Phase 1 Dose-Escalation, Food Effect, and Drug–Drug Interaction Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of the MALT1 Inhibitor, SGR-1505, in Healthy Volunteers
Gupta, V. K., Yoo, B., Weiss, D., Basile, F. G., Schuck, E., Rubino, C. M., Zhang, S., Maxwell, S. E., Zheng, W., Tan, J. B. L., Stenehjem, D., Watkins, P. B., Dugan, M., Yin, W., Wright, D. H., Akinsanya, K. & Lickliter, J., Jan 2026, In: Clinical Pharmacology in Drug Development. 15, 1, e70008.Research output: Contribution to journal › Article › peer-review
Open Access -
Biomarker, treatment patterns, and survival differences in metastatic triple-negative breast cancer by race in the United States
Farrokhi, P., Park, L., Schmutz, H. W., Thompson, S. L., Lam, C., Bryan, J. & Stenehjem, D. D., Dec 2026, In: npj Breast Cancer. 12, 1, 76.Research output: Contribution to journal › Article › peer-review
Open Access
Press/Media
-
Hypothetically, Would Adderall Turn Joe Biden Into a Debate Whiz?
9/30/20
1 item of Media coverage
Press/Media: Expert Comment or Interview